1. High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance‐associated substitutions in hepatitis C genotype 3 infection. Issue 9 (14th March 2018) Authors: von Felden, J.; Vermehren, J.; Ingiliz, P.; Mauss, S.; Lutz, T.; Simon, K. G.; Busch, H. W.; Baumgarten, A.; Schewe, K.; Hueppe, D.; Boesecke, C.; Rockstroh, J. K.; Daeumer, M.; Luebke, N.; Timm, J.; Schulze zur Wiesch, J.; Sarrazin, C.; Christensen, S. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 9(2018) Page Start: 1288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗